Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Angiotensin-converting Enzyme
100%
Type 1 Diabetes Mellitus (T1DM)
100%
Severe Hypoglycemia
100%
Enzyme Activity
71%
Genotype
57%
Type I Diabetes
42%
Serum Angiotensin Converting Enzyme
42%
Hypoglycemia Unawareness
28%
Relative Risk
28%
Endurance Athletes
28%
Angiotensin-converting Enzyme Gene
14%
High Risk
14%
Diabetes
14%
Mild Hypoglycemia
14%
Hypoglycemia
14%
Hyperinsulinemic Hypoglycemia
14%
Hypoglycemic Episodes
14%
Hemoglobin A1c (HbA1c)
14%
C-peptide
14%
Regression Analysis
14%
Diabetes Duration
14%
Clinically Significant
14%
Diabetic Patients
14%
Angiotensin-converting Enzyme Inhibitor (ACEi)
14%
B Cells
14%
Angiotensin Receptor Antagonists
14%
Cell Function
14%
Significant Markers
14%
Functional Capacity
14%
Enzyme Concentration
14%
Substrate Availability
14%
Self-treatment
14%
Adult Outpatients
14%
Nursing and Health Professions
Insulin Dependent Diabetes Mellitus
100%
Hypoglycemia
100%
Dipeptidyl Carboxypeptidase
100%
Angiotensin Blood Level
20%
Athletes
13%
Outpatient
6%
Patient with Type 1 Diabetes
6%
Antidiabetic Agent
6%
Functional Status
6%
Diabetes Mellitus
6%
Angiotensin Receptor Antagonist
6%
Hemoglobin A
6%
Self Care
6%
Dipeptidyl Carboxypeptidase Inhibitor
6%
C Peptide
6%
Biochemistry, Genetics and Molecular Biology
Angiotensin-Converting Enzyme
100%
Enzyme Activity
45%
Genotyping
36%
Angiotensin Blood Level
27%
Awareness
18%
Angiotensin Receptor
9%
Prospective Study
9%
Allele
9%
Cell Function
9%
C-Peptide
9%
Hemoglobin A
9%
Functional Status
9%
Receptor Antagonist
9%
Enzyme Inhibitor
9%